Thyrotropin receptor antibody and bone turnover markers in patients with newly-diagnosed Graves' disease

被引：0
|
作者：
樊亚亚 [1 ]
机构：
[1] Dept Endocrinol,The 1st Affil Hosp,Zhengzhou University
来源：
China Medical Abstracts (Internal Medicine) | 2022年 / 39卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R581 [甲状腺疾病];
学科分类号：
1002 ; 100201 ;
摘要：
Objective To investigate the correlation between the level of thyrotropin receptor antibody (TRAb) and bone turnover markers (BTMs) in patients with newlydiagnosed Graves’disease (GD). Methods The clinical data of GD patients who were newly-diagnosed in the First Affiliated Hospital of Zhengzhou University from October 2016 to June 2021 were collected,including free triiodothyronine (FT3),free thyroxine (FT4),thyroid stimulating hormone, thyroid related antibodies,N-terminal procollagen of type I collagen (PINP),N-terminal osteocalcin (N-MID), β-cross-linked C-telopeptide of type I (β-CTX),blood lipid and renal function,etc.
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [1] Bone turnover markers in newly diagnosed breast cancer patients
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S94 - S95
  • [2] Immunological markers of diabetes in newly-diagnosed Tunisian patients
    Harzallah, F.
    Haouat, E.
    Ben Brahim, A.
    Laadhar, L.
    Zitouni, M.
    Makni, S.
    Slimane, H.
    DIABETES & METABOLISM, 2008, 34 : A51 - A51
  • [3] Hepatic Dysfunction Related to Thyrotropin Receptor Antibody in Patients with Graves' Disease
    He, K.
    Hu, Y.
    Xu, X. -H.
    Mao, X. -M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (06) : 368 - 372
  • [4] The Relationship between Thyrotropin Receptor Antibody Levels and Intrathyroid Vascularity in Patients with Graves' Disease
    Shih, S. -R.
    Chang, J. -S.
    Lin, L. -C.
    Chang, Y. -C.
    Li, H. -Y.
    Lee, C. -Y.
    Chen, C. -M.
    Chang, T. -C.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2013, 121 (01) : 1 - 5
  • [5] Is Thyrotropin Receptor Antibody Positivity Associated with Cytology and Histopathology Results in Patients with Graves' Disease?
    Baser, Husniye
    Ince, Nurcan
    Erdogan, Beril Turan
    Topaloglu, Oya
    Aydin, Cevdet
    Yazicioglu, Mustafa Omer
    Dogan, Hayriye Tatli
    Ersoy, Reyhan
    Cakir, Bekir
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 26 (03) : 131 - 135
  • [6] The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy
    He, Mingqian
    Wang, Yue
    Wang, Jingya
    Sui, Jing
    Ding, Xi
    Chen, Ziyi
    Zhang, Meng
    Zhao, Yang
    Xie, Baosong
    Shi, Bingyin
    CYTOKINE, 2020, 127
  • [7] The thyrotropin receptor in graves' disease
    Rapoport, Basil
    McLachlan, Sandra M.
    THYROID, 2007, 17 (10) : 911 - 922
  • [8] EYE DISEASE IN NEWLY-DIAGNOSED LEPROSY PATIENTS IN EASTERN NEPAL
    LUBBERS, WJ
    SCHIPPER, A
    HOGEWEG, M
    DESOLDENHOFF, R
    LEPROSY REVIEW, 1994, 65 (03) : 231 - 238
  • [9] A Novel Monoclonal Antibody Degrades the Thyrotropin Receptor Autoantibodies in Graves' Disease
    Wolf, Jan
    Alt, Siegmund
    Kramer, Irene
    Kahaly, George Jean
    ENDOCRINE PRACTICE, 2023, 29 (07) : 553 - 559
  • [10] EVALUATION OF SERUM BASAL THYROTROPIN LEVELS AND THYROTROPIN RECEPTOR ANTIBODY ACTIVITIES AS PROGNOSTIC MARKERS FOR DISCONTINUATION OF ANTITHYROID DRUG-TREATMENT IN PATIENTS WITH GRAVES-DISEASE
    CHO, BY
    SHONG, MH
    YI, KH
    LEE, HK
    KOH, CS
    MIN, HK
    CLINICAL ENDOCRINOLOGY, 1992, 36 (06) : 585 - 590
12345